Search Results 1741-1750 of 17603 for Mindful Birth Control

1. A Study to Identify Novel High Quality Methylated DNA Markers in Renal Tumors - Mayo Clinic

   EXCLUSION CRITERIA - Renal Control Tissue: Patient has von Hippel-Lindau disease (VHL), Hereditary leiomyomatosis and renal cell cancer (HLRCC), Hereditary ...

2. A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method - Mayo Clinic

   Preterm infants, approximately equal number of male and female preterm infants with gestational age at birth <37 weeks or birth weight <1500 grams.

3. Healthy aging In-Depth - Mayo Clinic

   Centers for Disease Control and Prevention. https://www.cdc.gov/healthyweight/healthy_eating/portion_size.html. Accessed April 10, 2023. AskMayoExpert ...

4. Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, And B-LLy - Mayo Clinic

   Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for the duration of study participation. For ...

5. General Anesthesia Clinical Trials - Mayo Clinic Research

   The purpose of this study is to compare two methods of postoperative pain management for patients who have undergone total knee replacement surgery. . Mayo ...

6. Premature birth - Doctors and departments - Mayo Clinic

   Here's what you need to know about caring for a premature baby and the possible health problems of a preterm birth.

7. Publications - Kaitlin M. Moran, M.D. - Mayo Clinic

   Ogunlade SB, Wang L, Maimone S, Robinson KA, Moran KM, Leon A, Morozov AP, Nwachukwu CT, Letter HP. Mammogram-based AI risk assessment in patients with ...

8. A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis - Mayo Clinic

   Female who is pregnant, breast-feeding or intends to become pregnant or is of childbearing potential and not using highly effective contraceptive method.

9. Publications - Brian W. Hardaway, M.D. - Mayo Clinic

   Ghazal R, Wang M, Srinivas AN, Cao JJ, Vyas H, Liu D, Nair A, Smith BH, Wang L, Yip DS, Patel PC, Steidley DE, Hardaway BW, Clavell AL, Kushwaha SS, ...

10. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fruquintinib in Patients with Solid Tumors - Mayo Clinic

    ... contraception that results in a low failure rate ( < 1% per ... Previous medical history of hepatitis B virus (HBV) infection regardless of drug control ...